Table 2.
Prevalence rate (PR) | No. peptides | Repetitive peptides | E-rich peptides | E-rich repetitive peptides | |||
---|---|---|---|---|---|---|---|
No. | Proportion of total peptides (%) | No. | Proportion of total peptides (%) | No. | Proportion of repetitive peptides (%) | ||
≥80% | 12 | 11 | 91.7 | 10 | 83.3 | 10 | 90.9 |
<80%, ≥60% | 16 | 9 | 56.3 | 8 | 50.0 | 7 | 77.8 |
<60%, ≥50% | 29 | 10 | 34.5 | 5 | 17.2 | 3 | 30.0 |
<50%, ≥40% | 46 | 15 | 32.6 | 7 | 15.2 | 5 | 33.3 |
<40%, ≥30% | 116 | 27 | 23.3 | 17 | 14.7 | 12 | 44.4 |
<30%, ≥20% | 211 | 25 | 11.8 | 15 | 7.1 | 7 | 28.0 |
<20%, ≥10% | 364 | 21 | 5.8 | 19 | 5.2 | 9 | 42.9 |
Total | 794 | 118 | 1.5 | 81 | 1.0 | 53 | 44.9 |
Peptides with FM-PR ≥ 10%, Healthy-PR <10%, and FM-PR/Healthy-PR ≥ 2 were considered to be positively recognized peptides. Glutamic (E)-rich cutoff = 30%.